BENATTI, Piero
 Distribuzione geografica
Continente #
NA - Nord America 19.363
AS - Asia 7.057
EU - Europa 6.071
SA - Sud America 981
AF - Africa 148
Continente sconosciuto - Info sul continente non disponibili 117
OC - Oceania 29
Totale 33.766
Nazione #
US - Stati Uniti d'America 19.002
SG - Singapore 2.672
GB - Regno Unito 2.491
CN - Cina 1.656
IT - Italia 776
HK - Hong Kong 766
BR - Brasile 757
VN - Vietnam 598
SE - Svezia 590
DE - Germania 575
UA - Ucraina 362
FI - Finlandia 321
BD - Bangladesh 304
TR - Turchia 264
RU - Federazione Russa 255
FR - Francia 252
KR - Corea 171
CA - Canada 168
IN - India 139
BG - Bulgaria 123
AR - Argentina 72
ID - Indonesia 65
IQ - Iraq 65
MX - Messico 63
JP - Giappone 54
NL - Olanda 50
BE - Belgio 46
IE - Irlanda 46
ZA - Sudafrica 46
PK - Pakistan 42
AE - Emirati Arabi Uniti 41
ES - Italia 41
CO - Colombia 33
EC - Ecuador 29
CL - Cile 27
CR - Costa Rica 27
MY - Malesia 27
UZ - Uzbekistan 27
VE - Venezuela 26
AU - Australia 24
DZ - Algeria 20
PL - Polonia 20
MA - Marocco 19
PH - Filippine 17
CZ - Repubblica Ceca 16
LT - Lituania 16
NP - Nepal 16
SA - Arabia Saudita 16
TH - Thailandia 16
TW - Taiwan 16
AT - Austria 15
JM - Giamaica 15
SV - El Salvador 14
IL - Israele 13
EG - Egitto 12
GT - Guatemala 12
PY - Paraguay 12
JO - Giordania 11
KE - Kenya 11
PR - Porto Rico 11
AZ - Azerbaigian 10
TT - Trinidad e Tobago 10
NI - Nicaragua 9
PE - Perù 9
TN - Tunisia 9
PT - Portogallo 8
UY - Uruguay 8
AL - Albania 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
HU - Ungheria 7
DK - Danimarca 6
GP - Guadalupe 6
HN - Honduras 6
IR - Iran 6
LV - Lettonia 6
SY - Repubblica araba siriana 6
CH - Svizzera 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
PA - Panama 5
RO - Romania 5
SN - Senegal 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
CW - ???statistics.table.value.countryCode.CW??? 4
EE - Estonia 4
GR - Grecia 4
HR - Croazia 4
LB - Libano 4
MD - Moldavia 4
RS - Serbia 4
AM - Armenia 3
BH - Bahrain 3
CG - Congo 3
KG - Kirghizistan 3
LK - Sri Lanka 3
OM - Oman 3
PS - Palestinian Territory 3
SI - Slovenia 3
Totale 33.608
Città #
Ashburn 2.281
Southend 1.847
Singapore 1.842
Santa Clara 1.430
Fairfield 1.192
Woodbridge 868
Chicago 838
San Jose 761
Hong Kong 750
Houston 720
Chandler 663
Jacksonville 631
Los Angeles 561
Wilmington 505
Dearborn 500
Ann Arbor 477
Seattle 461
Council Bluffs 437
Hefei 432
Cambridge 431
Salt Lake City 364
Nyköping 352
Beijing 321
London 275
New York 197
Helsinki 196
Elk Grove Village 179
Ho Chi Minh City 174
Izmir 161
Tampa 161
Hanoi 154
The Dalles 151
Seoul 137
Princeton 132
Dallas 130
Modena 127
San Diego 126
Sofia 119
Eugene 113
Milan 99
Lancaster 98
Frankfurt am Main 95
Sterling 94
São Paulo 93
Lauterbourg 92
Buffalo 88
Columbus 82
Shanghai 81
Boardman 79
Bremen 70
Miami 70
Moscow 66
Phoenix 66
Des Moines 64
Munich 56
Detroit 48
Atlanta 46
Dulles 43
Falls Church 42
Tokyo 41
Toronto 40
Dublin 39
Orem 39
Rome 37
Brussels 35
Da Nang 35
Kansas City 34
Pittsburgh 34
Fremont 32
Jakarta 31
Haiphong 29
Mexico City 28
Rio de Janeiro 27
Chennai 25
Guangzhou 25
Hounslow 25
Ottawa 25
Tashkent 25
Denver 24
Nanjing 24
San Francisco 24
Kunming 23
North Bergen 23
Baghdad 22
San José 21
Belo Horizonte 20
Jersey City 20
Naples 20
Norwalk 20
Washington 19
Brooklyn 18
Changsha 18
Dhaka 18
Montreal 18
Philadelphia 17
Turku 17
Curitiba 16
Las Vegas 16
Manchester 16
Mumbai 16
Totale 23.704
Nome #
EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century 520
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 474
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 472
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 463
Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. 457
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 453
Differentiated Thyroid Carcinoma (DTC) in a Young Woman with Peutz-Jeghers Syndrome: are these Two Conditions Associated? 451
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 439
Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life. 431
A two-locus model for hereditary non-polyposis colorectal cancer in Modena, Italy 430
Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics 420
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 418
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 415
Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry 415
A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability. 406
Microsatellite instability in multiple colorectal tumors 404
IDENTIFICATION OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER IN THE GENERAL-POPULATION - THE 6-YEAR EXPERIENCE OF A POPULATION-BASED REGISTRY 402
Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms. 399
Aetiology of colorectal cancer and relevance of monogenic inheritance. 397
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 389
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 387
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 378
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 376
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 375
Survival from salivary glands adenoid cystic carcinoma in European populations. 372
Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis. 369
The non-invasive mechanical ventilation: the experience of the department of Internal Medicine and Critical Area of the Polyclinic Hospital of Modena 364
Myeloperoxidase-positive cell infiltration of normal colorectal mucosa is related to body fatness and is predictive of adenoma occurrence 360
Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Steps of Colorectal Carcinogenesis 360
Survival analysis in families affected by hereditary non-polyposis colorectal cancer 353
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 350
Clinical features and colorectal cancer survival: an attempt to explain differences between two different Italian regions. 349
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 348
Investigation of APC mutations in a Turkish familial adenomatous polyposis family by heterodublex analysis 346
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 340
Carcinoma papillare e Sindrome di Peutz-Jeghers: una rara associazione 339
Problems in the identification of hereditary nonpolyposis colorectal cancer in two families with late development of full-blown clinical spectrum 338
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary 337
Microsatellite instability and colorectal cancer prognosis. 336
Small bowel carcinoma in hereditary nonpolyposis colorectal cancer 334
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 333
Clinical features of colorectal cancer patients in advanced age: a population-based approach 332
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis 328
Biological characterization of mucinous carcinoma of the colon and rectum 325
Cancer prevalence in Italian cancer registry areas: The ITAPREVAL study 320
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 320
Prognostic relevance of MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer patients. 319
Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer. 317
Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree 314
I tumori in Italia. Rapporto 2011: La sopravvivenza dei pazienti oncologici in Italia 312
In response. Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability. 311
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 309
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 308
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States 307
Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-year experience of 2 population-based colorectal-cancer registries 306
Clinical and molecular features of attenuated adenomatous polyposis in northern Italy. 305
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 304
Colorectal carcinoma in different age groups: A population based investigation 300
Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: a population-based study 297
A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability. 293
[Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients] 288
Prevalence of differentiated thyroid cancer is relevant in patients with familial adenomatous polyposis: a case-control, prospective study 286
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 286
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 284
Survival from rare cancer in adults: A population-based study 275
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 275
Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy 274
Clinical and biologic heterogeneity of Hereditary NonPolyposis Colorectal Cancer. 273
Collection of Italian hereditary non-polyposis colorectal cancer (HNPCC) pedigrees 268
Clinical features and genotype-phenotype correlations in 41 Italian families with Adenomatosis Coli 266
Microsatellite instability and prognosis of colorectal cancer 261
CANCER OCCURRENCE IN THE FOLLOW-UP OF 25 FAMILIES WITH HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER (HNPCC) 260
Caratterizzazione immunoistochimica e biomolecolare del carcinoma colorettale giovanile 260
Epidemiologic and genetic factor in colorectal cancer: development of cancer in dizygotic twins in a family with Lynch syndrome 258
Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer. 257
Italian cancer figures, report 2013: Multiple tumours 257
Survival for colon and rectal cancer in a population-based cancer registry 256
Alternative marker panel for Microsatellite Instability analysis in deection of contitutional MLH1 and MSH2 mutations. 256
Il registro dei tumori colorettali 250
Phenotype-genotype correlations in an extended family with adenomatosis coli and an unusual APC gene mutation 245
Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC". A population-based study in Northern Italy. Colorectal Cancer Study Group. 244
Identification and biomolecular characterization of Muir-Torre Syndrome 242
Frequency and type of colorectal tumors in asymptomatic high-risk individuals in families with hereditary nonpolyposis colorectal cancer 234
GENETIC EPIDEMIOLOGY OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER 232
Epidemiologia dei tumori del colon-retto. Incidenza, mortalità, familiarità e sopravvivenza nella ex USL di Modena, 1984-1998. 231
Two different marker panels for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 229
HMSH6 immunohistochemistry in patients with clinical suspicion of Hereditary Non-Polyposis Colorectal Cancer. 226
Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer 226
The EUROCARE-3 database: Methodology of data collection, standardisation, quality control and statistical analysis 222
Inheritance and susceptibility to tumours of the large bowel: A new classification of colorectal malignancies 221
Epidemiology of cancer of the large bowel - The 12-year experience of a specialized registry in Northern Italy 215
Genetic epidemiology of Hereditary Non-Polyposis Colorectal Cancer syndromes in Modena, Italy: results of a complex segregation analysis. 215
Two different marker panels for microsatellie instability analysis in detection of constitutional MLH1 and MSH2 mutations. 211
The role of hPMS1 and hPMS2 in predisposing to colorectal cancer 210
Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis 207
Higher prevalence of nodular goiter and thyroid carcinoma in patients with familial adenomatous poliposis (FAP) 202
MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer. 197
Higher prevalence of nodular goiter and thyroid carcinoma in patients with familial adenomatous poliposis (FAP) 194
A West Nile Virus infection expressed as unilateral limb paralysis and complicated by Parsonage–Turner syndrome: a case report 186
hMSH6 immunohistochemistry in patients with clinical suspicion of Hereditary Non-Polyposis Colorectal Cancer. 184
Totale 31.689
Categoria #
all - tutte 136.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.408 0 0 0 0 39 88 143 76 221 138 470 233
2022/20231.821 224 194 145 172 229 314 20 165 204 12 83 59
2023/20241.288 48 69 77 80 351 130 123 157 30 23 64 136
2024/20254.685 145 60 68 337 1.011 710 340 285 465 176 462 626
2025/202611.752 554 336 670 1.806 3.712 552 1.064 452 801 777 525 503
2026/20272.894 238 464 858 1.326 8 0 0 0 0 0 0 0
Totale 33.766